![](https://www.radboudumc.nl/getmedia/b82298c7-f07a-45ae-a279-5b764b89ea66/STOCK-Research-program-header-1.aspx?width=1920&height=1153&ext=.jpg&type=BlockColumn1Zoom1)
![](https://www.radboudumc.nl/getmedia/b82298c7-f07a-45ae-a279-5b764b89ea66/STOCK-Research-program-header-1.aspx?width=1920&height=1153&ext=.jpg&type=BlockColumn2Zoom1)
Our purpose
We aim to unravel the pathophysiological basis of hematological disease, understand the biological consequences and define possibilities for therapeutic intervention.
Goals
- Improve diagnostic, predictive and monitoring modalities and prevent disease progression.
- Develop novel targeted forms of treatment, both immunological (antibody/DC vaccines/CART/NK) and chemical (PROTACS, small molecules) and perform investigator-initiated phase I/II trials.
- Improve quality of life by reducing early and late treatment-related toxicity and avoiding disease progression.
- Enhance patient engagement and shared decision making by personalized, eHealth-based care platforms.